Open Access Research article

Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence

Kim A Papp*, Darryl Toth and Les Rosoph

BMC Dermatology 2006, 6:9 doi:10.1186/1471-5945-6-9

Accesses  

  • Last 30 days: 38 accesses
  • Last 365 days: 442 accesses
  • All time: 5921 accesses

Cited by

Google Scholar: View citations

PubMed Central: View citations